152 related articles for article (PubMed ID: 29147627)
1. STAT1 gene deficient mice develop accelerated breast cancer growth and metastasis which is reduced by IL-17 blockade.
Varikuti S; Oghumu S; Elbaz M; Volpedo G; Ahirwar DK; Alarcon PC; Sperling RH; Moretti E; Pioso MS; Kimble J; Nasser MW; Ganju RK; Terrazas C; Satoskar AR
Oncoimmunology; 2017; 6(11):e1361088. PubMed ID: 29147627
[TBL] [Abstract][Full Text] [Related]
2. STAT1 Is Required for Decreasing Accumulation of Granulocytic Cells via IL-17 during Initial Steps of Colitis-Associated Cancer.
Delgado-Ramirez Y; Baltazar-Perez I; Martinez Y; Callejas BE; Medina-Andrade I; Olguín JE; Delgado-Buenrostro NL; Chirino YI; Terrazas LI; Leon-Cabrera S
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299314
[TBL] [Abstract][Full Text] [Related]
3. Deficiency in STAT1 Signaling Predisposes Gut Inflammation and Prompts Colorectal Cancer Development.
Leon-Cabrera S; Vázquez-Sandoval A; Molina-Guzman E; Delgado-Ramirez Y; Delgado-Buenrostro NL; Callejas BE; Chirino YI; Pérez-Plasencia C; Rodríguez-Sosa M; Olguín JE; Salinas C; Satoskar AR; Terrazas LI
Cancers (Basel); 2018 Sep; 10(9):. PubMed ID: 30235866
[TBL] [Abstract][Full Text] [Related]
4. CXCL17-derived CD11b
Hsu YL; Yen MC; Chang WA; Tsai PH; Pan YC; Liao SH; Kuo PL
Breast Cancer Res; 2019 Feb; 21(1):23. PubMed ID: 30755260
[TBL] [Abstract][Full Text] [Related]
5. Dimerization of EGFR and HER2 induces breast cancer cell motility through STAT1-dependent ACTA2 induction.
Jeon M; You D; Bae SY; Kim SW; Nam SJ; Kim HH; Kim S; Lee JE
Oncotarget; 2017 Aug; 8(31):50570-50581. PubMed ID: 28881584
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells.
Jovanovic IP; Pejnovic NN; Radosavljevic GD; Pantic JM; Milovanovic MZ; Arsenijevic NN; Lukic ML
Int J Cancer; 2014 Apr; 134(7):1669-82. PubMed ID: 24105680
[TBL] [Abstract][Full Text] [Related]
7. Splenectomy-Induced Leukocytosis Promotes Intratumoral Accumulation of Myeloid-Derived Suppressor Cells, Angiogenesis and Metastasis.
Sevmis M; Yoyen-Ermis D; Aydin C; Bilgic E; Korkusuz P; Uner A; Hamaloglu E; Esendagli G; Karakoc D
Immunol Invest; 2017 Oct; 46(7):663-676. PubMed ID: 28872973
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin directs the accumulation of interleukin-12 induced IFN gamma into tumors for enhancing STAT1 dependent antitumor effect.
Zhu S; Waguespack M; Barker SA; Li S
Clin Cancer Res; 2007 Jul; 13(14):4252-60. PubMed ID: 17634555
[TBL] [Abstract][Full Text] [Related]
9. SOCS3 Suppression Promoted the Recruitment of CD11b
Zhang W; Jiang M; Chen J; Zhang R; Ye Y; Liu P; Yu W; Yu J
Front Immunol; 2018; 9():1699. PubMed ID: 30083161
[TBL] [Abstract][Full Text] [Related]
10. Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation.
Kaplanov I; Carmi Y; Kornetsky R; Shemesh A; Shurin GV; Shurin MR; Dinarello CA; Voronov E; Apte RN
Proc Natl Acad Sci U S A; 2019 Jan; 116(4):1361-1369. PubMed ID: 30545915
[TBL] [Abstract][Full Text] [Related]
11. Stat1 negatively regulates angiogenesis, tumorigenicity and metastasis of tumor cells.
Huang S; Bucana CD; Van Arsdall M; Fidler IJ
Oncogene; 2002 Apr; 21(16):2504-12. PubMed ID: 11971185
[TBL] [Abstract][Full Text] [Related]
12. Role of signal transducer and activator of transcription 1 in murine allergen-induced airway remodeling and exacerbation by carbon nanotubes.
Thompson EA; Sayers BC; Glista-Baker EE; Shipkowski KA; Ihrie MD; Duke KS; Taylor AJ; Bonner JC
Am J Respir Cell Mol Biol; 2015 Nov; 53(5):625-36. PubMed ID: 25807359
[TBL] [Abstract][Full Text] [Related]
13. Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis.
Papageorgis P; Ozturk S; Lambert AW; Neophytou CM; Tzatsos A; Wong CK; Thiagalingam S; Constantinou AI
Breast Cancer Res; 2015 Jul; 17(1):98. PubMed ID: 26208975
[TBL] [Abstract][Full Text] [Related]
14. Stat1 deficiency in the host enhances interleukin-12-mediated tumor regression.
Torrero MN; Xia X; Henk W; Yu S; Li S
Cancer Res; 2006 Apr; 66(8):4461-7. PubMed ID: 16618773
[TBL] [Abstract][Full Text] [Related]
15. Naringenin prevents TGF-β1 secretion from breast cancer and suppresses pulmonary metastasis by inhibiting PKC activation.
Zhang F; Dong W; Zeng W; Zhang L; Zhang C; Qiu Y; Wang L; Yin X; Zhang C; Liang W
Breast Cancer Res; 2016 Apr; 18(1):38. PubMed ID: 27036297
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the Kit ligand/c-Kit axis attenuates metastasis in a mouse model mimicking local breast cancer relapse after radiotherapy.
Kuonen F; Laurent J; Secondini C; Lorusso G; Stehle JC; Rausch T; Faes-Van't Hull E; Bieler G; Alghisi GC; Schwendener R; Andrejevic-Blant S; Mirimanoff RO; Rüegg C
Clin Cancer Res; 2012 Aug; 18(16):4365-74. PubMed ID: 22711708
[TBL] [Abstract][Full Text] [Related]
17. Arginase inhibition suppresses lung metastasis in the 4T1 breast cancer model independently of the immunomodulatory and anti-metastatic effects of VEGFR-2 blockade.
Secondini C; Coquoz O; Spagnuolo L; Spinetti T; Peyvandi S; Ciarloni L; Botta F; Bourquin C; Rüegg C
Oncoimmunology; 2017; 6(6):e1316437. PubMed ID: 28680747
[TBL] [Abstract][Full Text] [Related]
18. The Yin/Yan of CCL2: a minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo.
Lavender N; Yang J; Chen SC; Sai J; Johnson CA; Owens P; Ayers GD; Richmond A
BMC Cancer; 2017 Jan; 17(1):88. PubMed ID: 28143493
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of signal transducer and activator of transcription-1-deficient mice to pulmonary fibrogenesis.
Walters DM; Antao-Menezes A; Ingram JL; Rice AB; Nyska A; Tani Y; Kleeberger SR; Bonner JC
Am J Pathol; 2005 Nov; 167(5):1221-9. PubMed ID: 16251407
[TBL] [Abstract][Full Text] [Related]
20. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
